Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group

Despite major treatment improvements over the past decades, pediatric acute myeloid leukemia (AML) is still a life-threatening malignancy with relapse rates up to 30% and survival rates below 75%. A better description of the pattern of molecular aberrations in childhood AML is needed to refine progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Marceau-Renaut, Alice, Duployez, Nicolas, Ducourneau, Benoît, Labopin, Myriam, Petit, Arnaud, Rousseau, Alexandra, Geffroy, Sandrine, Bucci, Maxime, Cuccuini, Wendy, Fenneteau, Odile, Ruminy, Philippe, Nelken, Brigitte, Ducassou, Stéphane, Gandemer, Virginie, Leblanc, Thierry, Michel, Gérard, Bertrand, Yves, Baruchel, André, Leverger, Guy, Preudhomme, Claude, Lapillonne, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745946/
https://www.ncbi.nlm.nih.gov/pubmed/31723759
http://dx.doi.org/10.1097/HS9.0000000000000031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745946/
https://www.ncbi.nlm.nih.gov/pubmed/31723759
http://dx.doi.org/10.1097/HS9.0000000000000031

Ejemplares similares